Evidence map›Paper›PMID 40979980›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2025

May Measurement Month 2022: an analysis of blood pressure screening results from Sudan.

Egbal A B Abukaraig, Thomas Beaney, Gabriele Kerr, Neil R Poulter, Hind Beheiry, Maha E H Daoud, Deena A A Mohamed, Omer I O Ahmed, Yasir H A Mohamed, Ibrahim A Elhassan and 1 more

Abstract read
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Egbal A B AbukaraigResearch and Development Centre, Alfajr College for Science and Technology, Al-Raqi Neighbourhood, Madani Street, Khartoum 11111, Sudan.
Thomas BeaneyImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.ORCID https://orcid.org/0000-0001-9709-7264
Gabriele KerrImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Neil R PoulterImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Hind BeheiryDepartment of Physiology, Educational Development and Research Centre, International University of Africa, Khartoum, Sudan.ORCID https://orcid.org/0000-0001-6905-1867
Maha E H DaoudDepartment of Cardiology, Alshab Teaching Hospital, Khartoum, Sudan.
Deena A A MohamedResearch and Development Centre, Alfajr College for Science and Technology, Al-Raqi Neighbourhood, Madani Street, Khartoum 11111, Sudan.
Omer I O AhmedPort Sudan Teaching Hospital, Emergency Department, Port Sudan, Sudan.
Yasir H A MohamedAtbara Teaching Hospital, Atbara, Sudan.
Ibrahim A ElhassanResearch and Development Centre, Alfajr College for Science and Technology, Al-Raqi Neighbourhood, Madani Street, Khartoum 11111, Sudan.
Ibtisam A AliDepartment of Cardiology, Al Zamzam University College and Ahmad Gasim Cardiac Centre, Khartoum, Sudan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The May Measurement Month (MMM) campaign was carried out in Sudan in 2022 with the aim of raising awareness of raised blood pressure (BP). Here, we report on the findings of the campaign. Adults aged ≥18 years were recruited opportunistically at the community spaces and educational institutes. Three seated BP readings were taken for each participant, along with completing a questionnaire on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg or being on antihypertensive medication. Controlled BP was described as being on antihypertensive medication with a BP < 140/90 mmHg. Multiple imputation was used to estimate any missing BP readings. In total, 16 051 were screened with a mean age of 37.5 ± 15.9 years and 57.7% of them were females. Of all screened participants, 4604 (28.7%) had hypertension, of whom 2038 (44.27%) were aware of being hypertensive, and 1864 (40.5%) were on antihypertensive medication. Of those on antihypertensive medication, 808 (43.3%) had controlled BP, and of all participants with hypertension, 17.5% had controlled BP. Only 6960 (43.4%) of the total participants had their BP measured within the last 12 months. The MMM campaign in Sudan identified a high percentage of significant numbers of participants with either untreated or inadequately treated hypertension. The previously diagnosed cases were a small proportion of the disease load, a situation that deserves extensive efforts of awareness-raising campaigns and community screening.

Indexed as

Blood pressureControlHypertensionScreeningSudanTreatment

Identifiers

PMID40979980
PMCPMC12449206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.